Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Radiotherapy (RT) remains a cornerstone of Breast cancer (BC) treatment, but its effectiveness is hindered by challenges such as tumor hypoxia and lack of selectivity. Nanoparticles (NPs), especially those composed of high-Z materials like bismuth oxide (Bi₂O₃), have emerged as promising radiosensitizers to enhance RT efficacy. This study aims to compare the radiosensitizing effects of two functionalized Bi₂O₃-based NPs, chitosan (CS)-coated Bi₂O₃ NPs conjugated with 5-aminolevulinic acid and curcumin (Bi₂O₃/CS@5-ALA-CUR), and β-cyclodextrin (PCD)-coated Bi₂O₃ NPs conjugated with curcumin and glucose (Bi₂O₃@PCD-CUR-Glu), for targeted BC RT. Two Bi₂O₃-based NP formulations were synthesized and characterized for size, surface charge, and drug loading. Then, NPs were characterized fully. Their radiosensitizing effects were tested in-vitro using SKBr-3 and NIH3T3 cells, assessing cytotoxicity, reactive oxygen species (ROS) generation, and migration inhibition. In-vivo tumor growth inhibition was evaluated in a BALB/c mouse model with 6 MV X-rays (2 Gy) irradiation. Both NP formulations exhibited high biocompatibility and selective cytotoxicity towards SKBr-3 cells, reducing cell viability by 60–69% at 160 µg/mL. Bi₂O₃/CS@5-ALA-CUR NPs showed superior radiosensitization, reducing cell viability by 64% under 2 Gy irradiation. The functionalized NPs enhanced ROS generation, alleviated hypoxia (reducing hypoxic cell viability by 17%), and inhibited migration. In-vivo, Bi₂O₃/CS@5-ALA-CUR NPs combined with 2 Gy irradiation reduced tumor volume by 64%, compared to a 50% reduction with Bi₂O₃@PCD-CUR-Glu NPs. The study demonstrates that Bi₂O₃/CS@5-ALA-CUR NPs are more effective radiosensitizers than Bi₂O₃@PCD-CUR-Glu NPs in BC RT. These findings highlight the potential of modified Bi₂O₃ NPs in overcoming the limitations of traditional RT, providing a promising approach for improving treatment outcomes in BC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pal, K., Roy, S., Parida, P. K., Dutta, A., Bardhan, S., Das, S., Jana, K., & Karmakar, P. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.10.071 · Cited by 116
RetractedSurface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles
Yue, Z.-G., Wei, W., Lv, P.-P., Yue, H., Wang, L.-Y., Su, Z.-G., & Ma, G.-H. (2011) · Biomacromolecules · doi:10.1021/bm101482r · Cited by 567
Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
Patel, S. S., Acharya, A., Ray, R. S., Agrawal, R., Raghuwanshi, R., & Jain, P. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1552244 · Cited by 511
Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes
Chen, B., Le, W., Wang, Y., Li, Z., Wang, D., Lin, L., Cui, S., Hu, J. J., Hu, Y., Yang, P., et al. (2016) · Theranostics · doi:10.7150/thno.16358 · Cited by 396
Nanoscintillator-Mediated X-ray Inducible Photodynamic Therapy for In Vivo Cancer Treatment
Chen, H., Wang, G. D., Chuang, Y.-J., Zhen, Z., Chen, X., Biddinger, P., Hao, Z., Liu, F., Shen, B., Pan, Z., et al. (2015) · Nano Letters · doi:10.1021/nl504044p · Cited by 381
Yan, J., Wang, G., Xie, L., Tian, H., Li, J., Li, B., Sang, W., Li, W., Zhang, Z., & Dai, Y. (2022) · Advanced Materials · doi:10.1002/adma.202105783 · Cited by 253
Deng, J., Xu, S., Hu, W., Xun, X., Zheng, L., & Su, M. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.048 · Cited by 234
Wu, Y., Liao, W., Dawuda, M. M., Hu, L., & Yu, J. (2018) · Plant Growth Regulation · doi:10.1007/s10725-018-0463-8 · Cited by 173
PGMD/curcumin nanoparticles for the treatment of breast cancer
Kumari, M. R., Sharma, N., Manchanda, R., Gupta, N., Syed, A., Bahkali, A. H., & Nimesh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81701-x · Cited by 140
Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer
Farghadani, R., & Naidu, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042144 · Cited by 133
Research works printed but not linked: 4
- Abdollahi BB et al (2020) Main approaches to enhance radiosensitization in cancer cells by nanoparticles: a systematic review. Adv Pharm Bull 11(2):212
- Khosravi H et al (2024) Bismuth Selenide nanoparticles enhance radiation sensitivity in colon cancer cells in-vitro. Biochem Biophys Rep 38:101732
- Yu H et al (2022) Bismuth nanomaterials as contrast agents for radiography and computed tomography imaging and their quality/safety considerations. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol 14(6):e1801
- Zare F et al (2026) Targeted radiosensitization in cancer radiotherapy using functionalized nanocarriers: a systematic review.
Cited by
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
Metadata
- Authors
- Dastgir, M., Ayyami, Y., Ghorbani, M., Yektamanesh, M., Ghasemi Jangjoo, A., Zamani, H., Jazzi, S. S., Mehrizi, O. A., Mortezazadeh, T., & Malekzadeh, R.
- Affiliations
- Tabriz University of Medical Sciences (IR)
- Corresponding author
- Malekzadeh, Reza
- Venue
- Cancer Nanotechnology
- Published
- 2025-12-24
- Volume
- 17
- Issue
- 1
- ISSN
- 1868-6958 (ISSN-L)
- 1868-6966
- OpenAlex
- W7117131100
- Cited by
- 4
- References
- 57
- Citations by year
- 2026: 4
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor, 34 d)
- Locations
- Cancer Nanotechnology (publishedVersion, cc-by-nc-nd)
- Funders
- Tabriz University of Medical Sciences (Grant #75243)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- breast cancer, radiosensitization, bismuth oxide nanoparticles, chitosan coating, β-cyclodextrin, curcumin, 5-aminolevulinic acid, tumor hypoxia, reactive oxygen species, cell migration inhibition, tumor growth inhibition, high-Z nanoparticles, targeted radiotherapy, nanoparticle drug delivery, SK-BR-3 cells, tumor xenografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid. https://app.cochat.ai/papers/10.1186/s12645-025-00359-6
- The paper
- Dastgir, M., Ayyami, Y., Ghorbani, M., Yektamanesh, M., Ghasemi Jangjoo, A., Zamani, H., Jazzi, S. S., Mehrizi, O. A., Mortezazadeh, T., & Malekzadeh, R. (2026). Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid. Cancer Nanotechnology. https://doi.org/10.1186/s12645-025-00359-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.